Norway· NO-ID_A7D7BD07-A58A-4A0C-A120-A521720FEEF5
Spinraza
A nusinersen product containing nusinersen, registered in Norway by Biogen Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Nusinersen is registered in 13 of 19 countries.
Countries holding a registration under ATC M09AX07 (nusinersen), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Nusinersen · ATC M09AX07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nusinersen costs, country by country.
Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nusinersen · price per daily dose (0.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$531.69
The record
At a glance
FEST (Norway)- Active substance
- Nusinersen
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Norway (NO)
- ATC code
- M09AX07
- ATC class
- Nusinersen
- Defined daily dose
- 0.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_A7D7BD07-A58A-4A0C-A120-A521720FEEF5
- no_varenummer4588385NOK 1020442.4
- gtin5713219500784
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nusinersen in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSPINRAZA 12 MG SOLUCION INYECTABLEBiogen Netherlands B.V.
- FinlandSpinrazaBIOGEN NETHERLANDS B.V.
- FranceSPINRAZA 12 mg, solution injectableBIOGEN NETHERLANDS (PAYS-BAS)
- IrelandSpinraza 12 mg solution for injectionBiogen Netherlands B.V.
- IcelandSpinrazaBiogen Netherlands B.V.
- PolandSpinrazaBiogen Netherlands B.V.
- SwedenSpinraza 12 mg Injektionsvätska, lösningBiogen Netherlands B.V.
- NetherlandsSpinraza 2,4 mg/ml, oplossing voor injectieBiogen Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Spinraza
- Liechtenstein · Spinraza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/956edf85-bda3-4364-8a75-2d30a41ffe19 GET /v1/drugs/956edf85-bda3-4364-8a75-2d30a41ffe19?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Nusinersen",
"merkevare_id": "ID_A7D7BD07-A58A-4A0C-A120-A521720FEEF5",
"name_form_strength": "Spinraza inj, oppl 12 mg",
"prescription_group": "C"
}See everything about nusinersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.